Reply to “From Evidence to Impact: Bridging the Implementation Gap in Geriatric Deprescribing”
- 13 January 2026
- journal article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (4) , 1205-1206
Abstract
No abstract availableFunding Information
- Tel Aviv University
This publication has 9 references indexed in Scilit:
- From Evidence to Impact: Bridging the Implementation Gap in Geriatric DeprescribingJournal of the American Geriatrics Society, 2025
- Reply to: Inappropriate Prescribing and Medication Safety in Older AdultsJournal of the American Geriatrics Society, 2025
- A Prospective Study on Potentially Inappropriate Drug Use and All‐Cause Mortality in Community‐Dwelling Older AdultsJournal of the American Geriatrics Society, 2025
- Evaluating the role of clinical decision support systems in medication safety for older people: a systematic reviewAge and Ageing, 2025
- Deprescribing in Community-Dwelling Older AdultsJAMA Network Open, 2025
- STOPP/START criteria for potentially inappropriate prescribing in older people: version 3European Geriatric Medicine, 2023
- Self-rated Health Compared With Objectively Measured Health Status as a Tool for Mortality Risk Screening in Older Adults: 10-Year Follow-up of the Bambui Cohort Study of AgingAmerican Journal of Epidemiology, 2011
- Frailty in Older Adults: Evidence for a PhenotypeThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2001
- Senile Cataract and Glucose Intolerance: The Israel Study of Glucose Intolerance Obesity and Hypertension (The Israel GOH Study)Diabetes Care, 1984